BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38419419)

  • 1. Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
    Hu C; Wang S; Lin H; Wan Q; Zheng R; Zhu Y; Li M; Xu Y; Xu M; Zheng J; Chen L; Zeng T; Hu R; Ye Z; Shi L; Su Q; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Chen G; Dai M; Zhang D; Tang X; Gao Z; Shen F; Gu X; Luo Z; Qin Y; Chen L; Hou X; Huo Y; Li Q; Wang G; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Mu Y; Lai S; Li D; Ning G; Wang W; Hu W; Bi Y; Lu J;
    Diabetes Obes Metab; 2024 Jun; 26(6):2176-2187. PubMed ID: 38419419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.
    Gao M; Lv J; Yu C; Guo Y; Bian Z; Yang R; Du H; Yang L; Chen Y; Li Z; Zhang X; Chen J; Qi L; Chen Z; Huang T; Li L;
    PLoS Med; 2020 Oct; 17(10):e1003351. PubMed ID: 33125374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population.
    Dhana K; Koolhaas CM; van Rossum EF; Ikram MA; Hofman A; Kavousi M; Franco OH
    PLoS One; 2016; 11(4):e0154273. PubMed ID: 27100779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight or obesity increases the risk of cardiovascular disease among older Australian adults, even in the absence of cardiometabolic risk factors: a Bayesian survival analysis from the Hunter Community Study.
    Opio J; Wynne K; Attia J; Hancock S; Oldmeadow C; Kelly B; Inder K; McEvoy M
    Int J Obes (Lond); 2023 Feb; 47(2):117-125. PubMed ID: 36482073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and cardiovascular disease in cancer survivors.
    Ueno K; Kaneko H; Suzuki Y; Okada A; Matsuoka S; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Kamiya K; Ako J; Node K; Yasunaga H; Komuro I
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1062-1071. PubMed ID: 38515400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
    Wang T; Li M; Zeng T; Hu R; Xu Y; Xu M; Zhao Z; Chen Y; Wang S; Lin H; Yu X; Chen G; Su Q; Mu Y; Chen L; Tang X; Yan L; Qin G; Wan Q; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Shi L; Ning G; Bi Y; Wang W; Lu J
    Diabetes Care; 2022 Aug; 45(8):1863-1872. PubMed ID: 35700159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.
    Caleyachetty R; Thomas GN; Toulis KA; Mohammed N; Gokhale KM; Balachandran K; Nirantharakumar K
    J Am Coll Cardiol; 2017 Sep; 70(12):1429-1437. PubMed ID: 28911506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study.
    Kouvari M; Panagiotakos DB; Yannakoulia M; Georgousopoulou E; Critselis E; Chrysohoou C; Tousoulis D; Pitsavos C;
    Metabolism; 2019 Apr; 93():18-24. PubMed ID: 30639450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, metabolic health and clinical outcomes after incident cardiovascular disease: A nationwide population-based cohort study.
    Akyea RK; Ntaios G; Doehner W
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2653-2662. PubMed ID: 37806948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
    Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
    BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review.
    Roberson LL; Aneni EC; Maziak W; Agatston A; Feldman T; Rouseff M; Tran T; Blaha MJ; Santos RD; Sposito A; Al-Mallah MH; Blankstein R; Budoff MJ; Nasir K
    BMC Public Health; 2014 Jan; 14():14. PubMed ID: 24400816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
    Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
    JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Residential Greenness, Cardiometabolic Disorders, and Cardiovascular Disease Among Adults in China.
    Yang BY; Hu LW; Jalaludin B; Knibbs LD; Markevych I; Heinrich J; Bloom MS; Morawska L; Lin S; Jalava P; Roponen M; Gao M; Chen DH; Zhou Y; Yu HY; Liu RQ; Zeng XW; Zeeshan M; Guo Y; Yu Y; Dong GH
    JAMA Netw Open; 2020 Sep; 3(9):e2017507. PubMed ID: 32955574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.